CanMed Clinical Research Inc.

Victoria, British Columbia V8T5GI

0 studies enrolling now · 18 studies all time

What they study most

Alzheimer Disease, Benign Prostatic Hypertrophy, Bladder Cancer, Bladder Neoplasms, Bladder Tumors, Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Lower Urinary Tract Symptoms (LUTS), Nocturia, Prostate Cancer, Prostatic Hyperplasia, Stress Urinary Incontinence, Urinary Bladder Cancer

Studies at this site

• Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer — Completed
• An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis — Completed
• Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ — Completed
• Bulking Agents for the Treatment of Stress Urinary Incontinence in Females — Completed
• Adjustable Continence Therapy (ACT) Device for the Treatment of Female Stress Urinary Incontinence — Completed
• ProACT Therapy for the Treatment of Stress Urinary Incontinence in Males — Completed
• Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612) — Completed
• An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults — Completed
• Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia — Completed
• Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients — Completed
• Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients — Completed
• A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) — Completed
• A Trial of Degarelix in Patients With Prostate Cancer — Completed
• A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer — Completed
• Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) — Completed
• A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer — Completed
• 18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type — Completed
• Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS) — Stopped early